Developer of a novel class of antibiotics, under licence to major manufacturers. Including marketing profile, news archive and contacts in Toronto, Canada.

Develops therapeutics based upon peptide analogs, primarily in regulation of glucose metabolism. Includes links for investors and patients, product pipeline, and career enquiries to San Diego, California. (Nasdaq: AMLN)

Specializes in developing and manufacturing genetically engineered drugs; somatropin, interferon, including monoclonal affinity columns for recombinant subtypes, kits for fertility and sperm detection, in Hefei, China.

Developing natural therapeutics, with a focus on infectious diseases, cancer and quality-of-life medicines. Overview of extraction and nanoscale technologies, product pipeline and profile of company in Woburn, Massachusetts.

Development of cytokine analogs for cancer therapy, peptides for contraception, diagnosis and treatment of infertility. Includes introduction to technology, projects, key staff, and contacts for careers in Baesweiler, Germany.

Offers platform for supplying biopharmaceutical protein hormones, including diabetic treatment, for developing nations initially, followed by Western Europe and the USA, from Hamburg, Germany.

Established manufacturer of drug for treatment of multiple sclerosis, with research focusing on respiratory diseases and congestive heart failure. Offices throughout Europe, Canada with headquarters in Cambridge, Massachusetts.

Privately owned company focusing on fermentation technologies, with production and recovery for cholesterol-lowering and alpha-glucosidase inhibitor drugs. Based in Calgary Alberta, Canada.

Researches and develops therapies for debilitating, fatal, chronic genetic disorders causing enzyme deficiency of carbohydrate metabolism, such as phenylketonuria. Headquarters in Novato, California. (Nasdaq: BMRN).

Company engaged in the development of nutraceuticals, novel anti-infectives, such as the enzymatic modification of existing antibiotics. Domiciled in Zurich, Switzerland

Focused on the discovery and commercialization in the fields of reproduction and development, applying gene technologies to human and veterinary biotherapeutics. Ordering information for embryonic stem cells, manufacture of recombinant proteins, such as equine somatotropin, in Thebarton, South Australia.

Conglomerate industrial group, with more than 20 subsidiaries, engaged in the field of pharmaceutical production and manufacturers of recombinants, especially human insulin in Shanghai, China.

Products targeted on rare inherited disorders, kidney disease, orthopaedics, transplant and immune disease, cancer, and diagnostic testing. Includes links to global subsidiaries, headquartered from Cambridge, Massachusetts (Nasdaq: GENZ)

Researches and develops proprietary pharmaceutical and diagnostic products based on genes and antibodies. Offers production facilities for therapeutic proteins, and other partnerships in Rockville, Maryland. (Nasdaq: HGSI)

Acquires, develops and commercializes innovative products for treating central nervous system, cardiovascular and other disorders. Includes product range and investor data from Lexington, Massachusetts. (Nasdaq: IDEV)

Company developing small-molecule drugs and recombinant DNA proteins, which regulate gene activity and genetic processes in cancer and other diseases. Includes product information for patients and professionals from San Diego, California. (Nasdaq: LGND)

Discovers, develops and manufactures drugs that focus in the areas of infectious, autoimmune and addictive diseases. Product overview for patients and physicians, with investor data from headquarters in Boca Raton, Florida.

Discovers and develops drugs targeting skeletal, endocrinological, gastrointestinal, and central nervous system. Includes glossary, stages in pipeline, careers in North America, and investment in Salt Lake City, Utah. (Nasdaq: NPSP).

Privately held company developing therapies for hemophilia and other genetic disorders, using recombinant Factor VIII and gene therapy. Includes clinical trial status, licensing, corporate profile and contacts in Bala Cynwyd, Pennsylvania.

Offers novel platforms for the production of protein therapeutics, as well as technology and processes for the purification and formulation. Includes preclinical status of products, and details of corporation in Leiden, The Netherlands.

Develops and commercializes innovative products for the treatment of melanoma, prostate cancer, viral diseases, including HIV. Information for investors, and details of the company in Tarrytown, New York. (Nasdaq: PGNX)

Offers cGMP-grade therapeutic protein production and know-how for candidates through late-stage research, clinical trials and their early industrial lifecycle. Includes overview of stages and contacts in Grenoble France.

Researches, develops, manufactures and markets synthetic version of protein A for monoclonal antibody processing, and peptides such as secretin for gastrointestinal and pediatric neurology. Details for investors and clinical programs run from Waltham Massachusetts. (Nasdaq: RGEN)

Develops and markets products targeted for treatment of cancer and diseases such as hepatitis B and C, cystic fibrosis and immune system disorders. Based in San Mateo, California. (Nasdaq: SCLN)

Specializing in multiple sclerosis, fertility, growth therapies and AIDS wasting. Includes company history and milestones. Includes products, pipeline, investor and media details, with headquarters in Geneva, Switzerland. (NYSE: SRA)

Offering rDNA derived streptokinase, human interferon alpha of type 2b, and hepatitis-B vaccine, with developments in endocrine, growth factors, immunotherapy, vaccine and diagnostics. Based in Hyderabad, India.

Corporate information on treatments for ophthalmia, hepatitis, dermatitis, angiopathy and illnesses associated with aging, from Beijing, China.